Recommendations
ACC/AHA/SCAI PCI Guidelines - British Cardiovascular Intervention ...
ACC/AHA/SCAI PCI Guidelines - British Cardiovascular Intervention ...
- No tags were found...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table 19. Invasive Versus Conservative Strategies in Unstable Angina Patients<br />
Patient<br />
Study Years Ref n Population Treatment Follow-Up<br />
Results<br />
Medical<br />
PCI Therapy P<br />
Comments<br />
TIMI-IIIB 1989-1992 (390) 1473 Patients 21 to 76 Medical therapy 6 wk<br />
years of age (tPA vs placebo)<br />
presenting within and early<br />
24 h of ischemic invasive or<br />
discomfort at rest conservative<br />
consistent with strategy<br />
unstable angina or 1 y<br />
non–Q-wave MI<br />
16.2% 18.1% NS<br />
combined combined<br />
primary primary<br />
end points end points<br />
12.4 % 10.6%<br />
Although no difference was found in combined<br />
primary end points (death, MI, positive ETT),<br />
the early invasive strategy was associated with<br />
shorter hospital stay and lower incidence of<br />
rehospitalization<br />
VANQWISH 1993-1996 (391) 920 Patients with an Invasive vs Average 23 mo<br />
evolving MI conservative<br />
32.9% 30.3% 0.35<br />
death death<br />
and MI and MI<br />
Fewer patients treated conservatively had death<br />
plus MI or death at hospital discharge at 1<br />
month and at 1 year; the invasive group had a<br />
higher CABG mortality rate (11.6% vs 3.4%)<br />
FRISC II 1996-1998 (304) 2457 Patient’s ischemic Early invasive 6 mo<br />
symptoms in previous therapy or<br />
48 hours accompanied noninvasive<br />
by ECG changes or treatment<br />
elevated markers strategy.<br />
Patients also<br />
received<br />
dalteparin<br />
or placebo for<br />
3 months<br />
9.4% 12.1% 0.031<br />
death death<br />
or MI or MI<br />
Invasive strategy was associated with 50%<br />
lower recurrent angina and hospital readmission<br />
rates<br />
TACTICS- 1997-1999 (393) 2220 UA and NSTEMI Medical therapy 6 mo<br />
TIMI 18 with ECG changes, (aspirin, heparin,<br />
elevated levels of tirofiban) and<br />
cardiac biomarkers, either early<br />
a history of CAD, invasive or<br />
or all 3 findings conservative<br />
(selectively<br />
invasive)<br />
treatment<br />
strategy<br />
7.3% 9.5% Less than<br />
death death 0.05<br />
or MI or MI<br />
Significant 22% relative risk reduction in composite<br />
end point of death, nonfatal MI, and<br />
rehospitalization<br />
RITA-3 1997-2001 (302) 1810 Suspected cardiac Medical therapy 1 y<br />
chest pain at rest and either early<br />
with documented invasive or<br />
evidence of CAD conservative<br />
(at least 1 of the (selectively<br />
following: ECG invasive)<br />
changes, pathological treatment<br />
Q waves, previous strategy; both<br />
arteriogram) groups received<br />
enoxaparin in<br />
addition to<br />
standard<br />
medical<br />
therapy<br />
7.6% 8.3% NS<br />
death death<br />
or MI or MI<br />
Similar results for death or MI between treatment<br />
groups; significant difference in primary<br />
end point (death, MI, refractory angina) due to<br />
halving of refractory angina in the intervention<br />
group<br />
CABG indicates coronary artery bypass graft surgery; CAD, coronary artery disease; ECG, electrocardiography; ETT, exercise treadmill test; MI, myocardial infarction; mo, month; n, number; NS, not significant; NSTEMI, non–ST-elevation myocardial infarction; PCI, percutaneous coronary intervention;<br />
Ref, reference; tPA, alteplase; UA, unstable angina; wk, week; and y, year.